AURKA inhibition mimics BRCAness

por Hirst, Jeff, Godwin, Andrew K.
Publicado 2017

Epimorphin-Induced MET Sensitizes Ovarian Cancer Cells to Platinum

por Yew, Kok-Hooi, Crow, Jennifer, Hirst, Jeff, Pressetto, Ziyan, Godwin, Andrew K.
Publicado 2013

Correction: Epimorphin-Induced MET Sensitizes Ovarian Cancer Cells to Platinum

por Yew, Kok-Hooi, Crow, Jennifer, Hirst, Jeff, Pessetto, Ziyan, Godwin, Andrew K.
Publicado 2013

Aurora A kinase regulates non-homologous end-joining and poly(ADP-ribose) polymerase function in ovarian carcinoma cells

por Do, Thuy-Vy, Hirst, Jeff, Hyter, Stephen, Roby, Katherine F., Godwin, Andrew K.
Publicado 2017

A Synthetic Lethality Screen Using a Focused siRNA Library to Identify Sensitizers to Dasatinib Therapy for the Treatment of Epithelial Ovarian Cancer

por Pathak, Harsh B., Zhou, Yan, Sethi, Geetika, Hirst, Jeff, Schilder, Russell J., Golemis, Erica A., Godwin, Andrew K.
Publicado 2015

Developing a genetic signature to predict drug response in ovarian cancer

por Hyter, Stephen, Hirst, Jeff, Pathak, Harsh, Pessetto, Ziyan Y., Koestler, Devin C., Raghavan, Rama, Pei, Dong, Godwin, Andrew K.
Publicado 2017

CCNE1 and BRD4 co-amplification in high-grade serous ovarian cancer is associated with poor clinical outcomes

por Petersen, Shariska, Wilson, Andrew J., Hirst, Jeff, Roby, Katherine F., Fadare, Oluwole, Crispens, Marta A., Beeghly-Fadiel, Alicia, Khabele, Dineo
Publicado 2020